Previous 10 | Next 10 |
IQVIA ( NYSE: IQV ) announces the first life sciences industry collaboration with Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, in China. The two companies will be providing solutions hosted in Mainland China leveraging Salesforce on Alibab...
Leading technology providers come together to bring innovative solutions addressing the unique business and compliance needs of the Greater China Region IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the ...
Summary IQVIA continues to demonstrate its propensity to generate growth and future value for shareholders. Here, we peel back the layers to demonstrate the underlying economics in the company's business model. Simply, it appears that IQV can continue funding its future growth initi...
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) will announce its fourth-quarter and full-year 2022 financial results before the market opens on Friday, February 10, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. Th...
Summary IQVIA is one of my favorite investments thanks to it being one of the leading CROs with a broad array of services. IQVIA has over 10,000 customers including big pharma. I was concerned IQVIA was going to struggle following the pandemic, but they have continued to deliver strong ...
The COVID-19 pandemic continues to impact pharmaceutical markets globally, and is estimated to expand the net cumulative pharmaceutical market by $500 billion from 2020 through 2027 Highest volume growth is expected in Latin America, Asia and Africa, driven by a mix of population growth and e...
Summary iShares Biotechnology has outperformed the S&P 500 during all 3 recessions in the U.S. since inception in early 2001. Healthcare and pharmaceutical shares have a strong track record of holding up during bear markets and recessions over the last 100 years. The Top 10 hold...
As we kick off 2023, there are a few signs that select stocks might be in ling for a great year. The stocks for healthcare companies IQVIA Holdings (NYSE: IQV) and Vertex Pharmaceuticals (NASDAQ: VRTX) , for example, have been on the upswing recently thanks to reports of incre...
Summary BMEZ’s portfolio has a combination of unknown small-cap "next generation" healthcare holdings and some familiar names in the field of biotechnology. Lack of diversification makes BMEZ susceptible to sector-specific risk. It also has a relatively high expense ratio despite...
Lasso announces a significant step forward in healthcare marketing measurement PR Newswire The healthcare marketing and analytics leader expands their Measurement Suite to include unprecedented audience and campaign insights. AUSTIN, Texas , Jan. 3, 2023 ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...